Literature DB >> 26288343

Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance.

Angela R Manser1, Markus Uhrberg2.   

Abstract

A key feature of human natural killer (NK) cells, which enables efficient recognition of infected and malignant target cells, is the expression of HLA class I-specific receptors of the KIR and NKG2 gene families. Cell-to-cell variability in receptor expression leads to the formation of complex NK cell repertoires. As outlined here, NK cells go through major changes from newborns to adults characterized by downregulation of the inhibitory NKG2A receptor and concomitant upregulation of KIR family members. This process is completed in young adults, and in the majority of individuals, KIR/NKG2A repertoires remain remarkably stable until old age. Nonetheless, age-related factors have the potential to majorly influence the complexity of NK cell repertoires: Firstly infection with HCMV is associated with major clonal expansions of terminally differentiated NKG2C- and KIR-expressing NK cells in certain individuals. Secondly, ineffective hematopoiesis can lead to immature and less diversified NK cell repertoires as observed in myelodysplastic syndrome (MDS), a malignant disease of the elderly. Thus, whereas in the majority of elderly the NK cell compartment appears to be highly stable in terms of function and phenotype, in a minority of subjects a breakdown of NK cell repertoire diversity is observed that might influence immune surveillance and healthy aging.

Entities:  

Keywords:  Aging; KIR; NKG2; Natural killer cell

Mesh:

Substances:

Year:  2015        PMID: 26288343     DOI: 10.1007/s00262-015-1750-0

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  30 in total

Review 1.  Homeostatic migration and distribution of innate immune cells in primary and secondary lymphoid organs with ageing.

Authors:  J Nikolich-Žugich; J S Davies
Journal:  Clin Exp Immunol       Date:  2017-03       Impact factor: 4.330

Review 2.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

Review 3.  Aging, cancer, and antitumor immunity.

Authors:  Hideki Ikeda; Yosuke Togashi
Journal:  Int J Clin Oncol       Date:  2021-03-30       Impact factor: 3.402

4.  SARS-CoV-2, COVID-19 and the Ageing Immune System.

Authors:  Juliet M Bartleson; Dina Radenkovic; Anthony J Covarrubias; David Furman; Daniel A Winer; Eric Verdin
Journal:  Nat Aging       Date:  2021-09-14

Review 5.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

Review 6.  The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer.

Authors:  Fabio Gomes; Rebecca Tay; Jaseela Chiramel; Raffaele Califano
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

Review 7.  Immunity to acute virus infections with advanced age.

Authors:  Janko Nikolich-Žugich; Christine M Bradshaw; Jennifer L Uhrlaub; Makiko Watanabe
Journal:  Curr Opin Virol       Date:  2020-11-04       Impact factor: 7.090

8.  Declined miR-181a-5p expression is associated with impaired natural killer cell development and function with aging.

Authors:  Jiao Lu; Shan Li; Xiaopeng Li; Wenming Zhao; Xuefeng Duan; Xiuling Gu; Jianqiao Xu; Bolan Yu; Luis J Sigal; Zhongjun Dong; Lixin Xie; Min Fang
Journal:  Aging Cell       Date:  2021-03-29       Impact factor: 9.304

9.  Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients.

Authors:  Tao Chen; Fangyu Zhou; Weili Jiang; Rui Mao; Hui Zheng; Linlin Qin; Chang Chen
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

10.  Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.

Authors:  Sylwia Koltan; Robert Debski; Andrzej Koltan; Elzbieta Grzesk; Barbara Tejza; Andrzej Eljaszewicz; Lidia Gackowska; Malgorzata Kubicka; Beata Kolodziej; Beata Kurylo-Rafinska; Izabela Kubiszewska; Malgorzata Wiese; Milena Januszewska; Jacek Michalkiewicz; Mariusz Wysocki; Jan Styczynski; Grzegorz Grzesk
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.